학술논문
'학술논문'
에서 검색결과 262건 | 목록
110~120
Academic Journal
In Gastroenterology May 2012 142(5) Supplement 1:S
Academic Journal
In Gastrointestinal Endoscopy April 2012 75(4) Supplement:AB469-AB469
Academic Journal
Huang, K. W.; Reebye, Vikash; Mintz, Paul J.; Saetrom, Pal; Swiderski, Piotr; Peng, L.; Liu, C.; Liu, X. X.; Jensen, Steen Lindkaer; Zacharoulis, Dimitris; Kostomitsopoulos, Nikos; Kasahara, Noriyaki; Nicholls, Joanna; Jiao, Long R.; Pai, Madhava; Spalding, Duncan; Farzaneh, Farzin; Mizandari, Malkhaz; Chikovani, Tina; Emara, Mohammed; Haoudi, Abdelali; Tomalia, Don; Rossi, John J.; Habib, Nagy A.
Academic Journal
Academic Journal
Parker CC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Urology, Salford Royal Hospital, Salford, UK.; Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Kynaston H; Division of Cancer and Genetics, Cardiff University Medical School, Cardiff, UK.; Catton CN; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Cross WR; Department of Urology, St James's University Hospital, Leeds, UK.; Petersen PM; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Persad RA; Department of Urology, Bristol Urological Institute, Bristol, UK.; Saad F; Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.; Bower LC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Logue J; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.; Payne H; The Prostate Centre, London, UK.; Forcat S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Goldstein C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Murphy C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Anderson J; Department of Clinical Oncology, St James's University Hospital, Leeds, UK.; Barkati M; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.; Bottomley DM; Department of Clinical Oncology, St James's University Hospital, Leeds, UK.; Branagan J; Northampton General Hospital, Northampton, UK.; Choudhury A; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK.; Chung PWM; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Cogley L; Derriford Hospital, Plymouth, UK.; Goh CL; Royal Surrey Hospital, Guildford, UK.; Hoskin P; Division of Cancer Sciences, University of Manchester, Manchester, UK; Mount Vernon Cancer Centre, Northwood, UK.; Khoo V; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Malone SC; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.; Masters L; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Morris SL; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Nabid A; Service de Radio-Oncologie, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.; Ong AD; Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.; Raman R; Kent Oncology Centre, Kent and Canterbury Hospital, Canterbury, UK.; Tarver KL; Department of Oncology, Queen's Hospital, Romford, UK.; Tree AC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Worlding J; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.; Wylie JP; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.; Zarkar AM; Department of Oncology, University Hospitals Birmingham, Birmingham, UK.; Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.; Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: mrcctu.radicals@ucl.ac.uk.
Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Academic Journal
Parker CC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Kynaston H; Division of Cancer and Genetics, Cardiff University Medical School, Cardiff, UK.; Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Urology, Salford Royal Hospital, Salford, UK.; Catton CN; Princess Margaret Cancer Centre, Toronto, ON, Canada.; Cross WR; Department of Urology, St James's University Hospital, Leeds, UK.; Petersen PM; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Persad RA; Department of Urology, Bristol Urological Institute, Bristol, UK.; Pugh CA; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Saad F; Department of Urology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.; Logue J; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.; Payne H; The Prostate Centre, London, UK.; Bower LC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Brawley C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Rauchenberger M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Barkati M; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.; Bottomley DM; Department of Clinical Oncology, St James's University Hospital, Leeds, UK.; Brasso K; Department of Urology, Copenhagen Prostate Cancer Center, Rigshospitalet, Copenhagen, Denmark.; Chung HT; Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Chung PWM; Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Conroy R; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Falconer A; Radiotherapy Department, Charing Cross Hospital, London, UK.; Ford V; Royal Devon and Exeter University NHS Foundation Trust, Exeter, UK.; Goh CL; Royal Surrey County Hospital, Guildford, UK.; Heath CM; Department of Clinical Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.; James ND; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Kim-Sing C; Department of Radiation Oncology, BC Cancer-Vancouver, Vancouver, BC, Canada.; Kodavatiganti R; Glan Clwyd Hospital, Betsi Cadwaladr University Health Board, Bangor, UK.; Malone SC; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.; Morris SL; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Nabid A; Service de Radio-Oncologie, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.; Ong AD; Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.; Raman R; Kent Oncology Centre, Kent and Canterbury Hospital, Canterbury, UK.; Rodda S; Bradford Teaching Hospitals, Bradford, UK.; Wells P; Barts Cancer Centre, St Bartholomew's Hospital, London, UK.; Worlding J; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.; Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.; Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: mrcctu.radicals@ucl.ac.uk.
Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Academic Journal
Academic Journal
Wang, Kai-Feng; Pan, Wei; Wang, Fei; Wang, Gao-Feng; Madhava, Pai; Pan, Hong-Ming; Kong, De-Xing; Liu, Xiang-Guan
Academic Journal
Academic Journal
검색 결과 제한하기
제한된 항목
[검색어] Pai, Madhava
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어